Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
Kyung-Yil Lee, Jung-Woo Rhim, Jin-Han Kang
Clin Exp Pediatr. 2020;63(4):117-118. Published online 2020 Apr 8 DOI: https://doi.org/10.3345/cep.2020.00290
|
Citations to this article as recorded by
A comparison of the Effects of Low and High Doses of Corticosteroids on Recovery of the Patients with Covid-19
Hamid Reza Samimagham, Ladan Hajiabdolrrasouli, Ali Salimi Asl, Fatemeh Khajavi Mayvan, Elham Boushehri, Mohsen Arabi, Mohammad Amin Abbasi, Mohammad Reza Moradi, Mitra Kazemi Jahromi
Journal of Research in Applied and Basic Medical S.2023; 9(2): 62. CrossRef Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease
Jung-Woo Rhim, Jin-Han Kang, Kyung-Yil Lee
Clinical and Experimental Pediatrics.2022; 65(4): 153. CrossRef Novel Targets of SARS-CoV-2 and Potential Inhibitors against
the Viral Targeted Proteins: A Review
G. Koteswara Reddy, V. Renuka, A. Chandana, K.S.Y. Navya
Asian Journal of Chemistry.2022; 34(6): 1354. CrossRef Common immunopathogenesis of central nervous system diseases: the protein-homeostasis-system hypothesis
Kyung-Yil Lee
Cell & Bioscience.2022;[Epub] CrossRef Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Luca Perico, Ariela Benigni, Federica Casiraghi, Lisa F. P. Ng, Laurent Renia, Giuseppe Remuzzi
Nature Reviews Nephrology.2021; 17(1): 46. CrossRef Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
Bader M. Jarai, Zachary Stillman, Kartik Bomb, April M. Kloxin, Catherine A. Fromen
ACS Biomaterials Science & Engineering.2021; 7(5): 1742. CrossRef The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis
Junning Wang, Weixia Yang, Puwen Chen, Jianbin Guo, Rui Liu, Pengfei Wen, Kun Li, Yao Lu, Tao Ma, Xiaoli Li, Siqing Qin, Yumin Zhang, Yakang Wang, Laura Pasin
PLOS ONE.2021; 16(4): e0249481. CrossRef Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
Giorgio Costagliola, Erika Spada, Rita Consolini
Pediatric Rheumatology.2021;[Epub] CrossRef Infection, Inflammation and Immunity in Covid-19 Infection
R. Cherneva, Z. Cherneva
Acta Medica Bulgarica.2021; 48(3): 77. CrossRef Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, Rachel Levantovsky, Louise Malle, Alvaro Moreira, Matthew D. Park, Luisanna Pia, Emma Risson, Miriam Saffern, Bérengère Salomé, Myvizhi Esai Selvan, Matthew P. Spindle
Immunity.2020; 52(6): 910. CrossRef Immunopathogenesis of COVID-19 and early immunomodulators
Kyung-Yil Lee, Jung-Woo Rhim, Jin-Han Kang
Clinical and Experimental Pediatrics.2020; 63(7): 239. CrossRef The solution on enigmas in COVID-19: the protein-homeostasis-system hypothesis
Kyung-Yil Lee
Journal of the Korean Medical Association.2020; 63(7): 366. CrossRef Overview of management of children with COVID-19
Dyah Kanya Wati, Arya Krisna Manggala
Clinical and Experimental Pediatrics.2020; 63(9): 345. CrossRef COVID-19–Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
Klaus Görlinger, Daniel Dirkmann, Ajay Gandhi, Paolo Simioni
Anesthesia & Analgesia.2020; 131(5): 1324. CrossRef
|